Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Daratumumab Biosimilar - Anti-CD38 mAb - Research Grade |
---|---|
Source | CAS 945721-28-8 |
Species | Homo sapiens |
Expression system | Mammalian cells |
Molecular weight | 148kDa |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Daratumumab,HuMax-CD38,CD38,anti-CD38 |
Reference | PX-TA1213 |
Note | For research use only. Not suitable for human use. |
Isotype | IgG1-kappa |
Clonality | Monoclonal Antibody |
Daratumumab is an immunoglobulin G1 kappa monoclonal antibody against CD38+ multiple myeloma cells.
Daratumumab Biosimilar - Anti-CD38 mAb, on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Immobilized CD38 Recombinant Protein (cat. No.PX-P4081) at 0.5µg/mL (100µL/well) can bind to Daratumumab Biosimilar - Anti-CD38 mAb (cat. No.PX-TA1213) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Reviews
Il n’y a pas encore d’avis.